Frontlight ResearchEarly access
Trial site
Centre Hospitalier National d'Ophtalmologie des Quize-Vingts
- 8running trials
- 2closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration2 trials
- Multiple sclerosis2 trials
- Myasthenia gravis2 trials
- Diabetic eye disease1 trial
- Giant cell arteritis1 trial
- Melanoma1 trial
- Neuromyelitis optica (NMOSD)1 trial
- Retinitis pigmentosa1 trial
- Phase
- Phase 38 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Not yet recruiting4 trials
- Recruiting3 trials
- Active, not recruiting1 trial
- Completed1 trial
- Withdrawn1 trial
- Lead sponsor
- UCB Biopharma SRL2 trials
- AbbVie1 trial
- Atsena Therapeutics Inc.1 trial
- Centre Hospitalier National D'Ophtalmologie Quinze-Vingts1 trial
- F. Hoffmann-La Roche AG1 trial
- and 4 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Study of an On-Body Injection System for Home Use of Ocrelizumab in People with Multiple Sclerosis
Recruiting
Recruiting
Recruiting
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration2 recruiting
- Myasthenia gravis2 recruiting
- Diabetic eye disease1 recruiting
- Melanoma1 recruiting
- Multiple sclerosis1 recruiting
- Neuromyelitis optica (NMOSD)1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026